RETRACTED: Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients Results From the Randomized OASIS Trial(Retracted article. See vol.68,pg.1608,2016)
BACKGROUND Nonrandomized studies have reported focal impulse and rotor modulation (FIRM)-guided ablation to be superior to pulmonary vein antrum isolation (PVAI) for persistent atrial fibrillation and long-standing persistent atrial fibrillation. OBJECTIVES This study sought to compare efficacy of FIRM ablation with or without PVAI versus PVAI plus non-PV trigger ablation in randomized persistent atrial fibrillation and long-standing persistent atrial fibrillation patients. METHODS Nonparoxysmal atrial fibrillation (AF) patients undergoing first ablation were randomized to FIRM only (group 1), FIRM + PVAI (group 2) or PVAI + posterior wall + non-PV trigger ablation (group 3). Primary endpoint was freedom from atrial tachycardia/AF. The secondary endpoint was acute procedural success, defined as AF termination, >= 10% slowing, or organization into atrial tachycardia. RESULTS A total of 113 patients were enrolled at 3 centers; 29 in group 1 and 42 each in groups 2 and 3. Group 1 enrollment was terminated early for futility. Focal drivers or rotors were detected in all group 1 and 2 patients. Procedure time was significantly shorter in group 3 versus groups 1 and 2 (p < 0.001). In groups 1 and 2, acute success after rotor-only ablation was achieved in 12 patients (41%) and 11 (26%), respectively. After 12 +/- 7 months' follow-up, 4 patients (14%), 22 (52.4%), and 32 (76%) in groups 1, 2, and 3, respectively, were AF/atrial tachycardia-free while off antiarrhythmic drugs (log-rank p < 0.0001). Group 3 patients experienced higher success compared with groups 1 (p < 0.001) and 2 (p = 0.02). CONCLUSIONS Outcomes were poor with rotor-only ablation. PVAI + rotor ablation had significantly longer procedure time and lower efficacy than PVAI + posterior wall + non-PV trigger-ablation. (C) 2016 by the American College of Cardiology Foundation.
基金:
Topera; Biosense Webster; St. Jude MedicalSt. Jude Medical
通讯机构:[1]St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, Dept Electrophysiol, Austin, TX USA;[3]Lexington Cardiol Cent Baptist, Dept Cardiol, Lexington, KY USA;[4]Capital Med Univ, Beijing Anzhen Hosp, Dept Electrophysiol, Beijing, Peoples R China;[5]Calif Pacific Med Ctr, Dept Electrophysiol & Arrhythmia Serv, San Francisco, CA USA;[6]Scripps Clin, Intervent Electrophysiol, La Jolla, CA 92037 USA;[7]Case Western Reserve Univ, Sch Med, Metro Hlth Med Ctr, Internal Med, Cleveland, OH USA;[8]Stanford Univ, Div Cardiol, Stanford, CA 94305 USA;[9]Univ Texas Austin, Dell Med Sch, Dept Internal Med, Austin, TX 78712 USA;[10]St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, 3000 North IH-35,Suite 720, Austin, TX 78705 USA
推荐引用方式(GB/T 7714):
Mohanty Sanghamitra,Gianni Carola,Mohanty Prasant,et al.RETRACTED: Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients Results From the Randomized OASIS Trial(Retracted article. See vol.68,pg.1608,2016)[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2016,68(3):274-282.doi:10.1016/j.jacc.2016.04.015.
APA:
Mohanty, Sanghamitra,Gianni, Carola,Mohanty, Prasant,Halbfass, Philipp,Metz, Tamara...&Natale, Andrea.(2016).RETRACTED: Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients Results From the Randomized OASIS Trial(Retracted article. See vol.68,pg.1608,2016).JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,68,(3)
MLA:
Mohanty, Sanghamitra,et al."RETRACTED: Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients Results From the Randomized OASIS Trial(Retracted article. See vol.68,pg.1608,2016)".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 68..3(2016):274-282